Optipharm.CO.,LTD (KOSDAQ:153710)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,220.00
-80.00 (-1.51%)
At close: Aug 28, 2025
-1.51%
Market Cap76.58B
Revenue (ttm)21.09B
Net Income (ttm)-2.36B
Shares Out14.67M
EPS (ttm)-161.51
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,485
Average Volume11,238
Open5,300.00
Previous Close5,300.00
Day's Range5,220.00 - 5,300.00
52-Week Range4,400.00 - 6,350.00
Beta-0.03
RSI56.48
Earnings Daten/a

About Optipharm.CO.,LTD

Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and changed its name to Optipharm.CO.,LTD in 2012. Optipharm.CO.,LTD was founded in 2000 and is based in Cheongju, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 153710
Full Company Profile

Financial Performance

In 2024, Optipharm.CO.,LTD's revenue was 19.64 billion, an increase of 13.03% compared to the previous year's 17.37 billion. Losses were -2.36 billion, -3.29% less than in 2023.

Financial Statements

News

There is no news available yet.